Press Releases - News & Events - Frequency Therapeutics

News & Events

Press Releases & News

Press Releases

Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss
- July 17, 2019

Frequency Therapeutics Announces Positive Phase 1/2 Data for Drug Candidate for Hearing Restoration
- April 9, 2019

Frequency Therapeutics to Present at Cowen & Company 39th Annual Health Care Conference
- March 6, 2019

Frequency Therapeutics to Present at the 42nd Annual Mid-Winter Meeting of the Association for Research in Otolaryngology
- February 7, 2019

Frequency Therapeutics Completes $42 Million Series B Financing
- January 7, 2019

Frequency Therapeutics to Present at the 37th Annual JP Morgan Healthcare Conference
- January 3, 2019

Frequency Therapeutics Completes Enrollment in Single Dose Safety Trial to Evaluate FX-322, a First-in-Class Drug Candidate for Hearing Restoration
- October 4, 2018

Frequency Therapeutics Strengthens Scientific Advisory Board with Addition of Leading Experts in Neurology, Stem Cell and Regenerative Medicine
- August 14, 2018

Frequency Therapeutics Initiates Phase 1/2 Single Dose Clinical Trial to Evaluate FX-322, a First-in-Class Drug Candidate for Hearing Restoration
- August 7, 2018

Frequency Therapeutics’ Co-founder and VP, Will McLean, Ph.D., Named To MIT Technology Review’s 2018 Innovators Under 35 List   
- June 27, 2018

U.S. Department of Defense Awards $2M Grant to Frequency Therapeutics  
- May 30, 2018

Frequency Therapeutics to Lead Featured Session at the American Academy of Audiology Annual Conference
- April 18, 2018

Frequency Therapeutics Continues Expansion of Leadership Team with Appointment of Dr. William Chin as Chief Medical Officer
- April 13, 2018

Science Magazine Recognizes Frequency Therapeutics’ PCA Regeneration Technology as a Breakthrough in Regenerative Medicine 
- March 20, 2018

Frequency Therapeutics Welcomes Former Otonomy CSO as Executive Vice President of Clinical Development
- March 12, 2018

Frequency Therapeutics to Present Corporate Update at Cowen & Company 38th Annual Health Care Conference
- March 6, 2018

Frequency Therapeutics Awarded Grant from JDRF to Generate Glucose-Responsive Insulin-Secreting Cells for Type 1 Diabetes Treatment Using a Small Molecule Approach  
- February 22, 2018

Three-way Collaboration with the U.S. Army, Harvard University and Frequency Therapeutics to Focus on Progenitor Cell Regeneration in Muscle
- February 15, 2018

Stem Cell Leaders Join Frequency Therapeutics’ PCA™ Regenerative Medicine Scientific Advisory Board
- December 28, 2017

Frequency Therapeutics' First-in-Human Safety Study of FX-322 for Hearing Restoration Achieves All Endpoints
- December 21, 2017

Frequency Therapeutics Presented Data at the International Society for Stem Cell Research Supporting Progenitor Cell Activation to Restore Healthy Function in Multiple Tissue Types
- June 19, 2017

Management Team Strengthened; Executive Level New Hire and Internal Promotion 
- April 27, 2017

Frequency Therapeutics Announces $32 Million Series A Financing to Support Clinical Development of a First-in-Class Hearing Restoration Therapeutic
- April 11, 2017

Frequency Therapeutics to Present at the 14th Stem Cell Research and Regenerative Medicine Conference
- April 5, 2017

Former Pfizer R&D President Joins Frequency Therapeutics' SAB
- March 30, 2017

Frequency Therapeutics to Present at Cowen & Company 37th Annual Healthcare Conference
- March 1, 2017

Frequency Therapeutics Announces a Revolutionary Small-molecule Approach to Restore Hearing Published in Cell Reports
- February 21, 2017

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
- January 5, 2017

Media Inquiries
Michael Lampe or 
Beth Kramli
Scient Public Relations
Tel: 484-575-5040


Frequency’s FX-322 improves hearing function in trial subjects
- Drug Development Technology, April 10, 2019

Frequency shows early positive results for small-molecule hearing loss therapy
- FierceBiotech, April 9, 2019

Frequency Therapeutics Announces Positive Results from Hearing Restoration Drug Trial
- The Hearing Review, April 9, 2019

Frequency Therapeutics Announces Positive Phase 1/2 Trial Results for Hearing Restoration Drug
- Hearing Health Matters, April 9, 2019

Recon: PBMs Blame Drugmakers for High Prices at Senate Hearing
- Regulatory Focus, April 9, 2019

Tackling the Burden and Shame of Hearing Loss
- UnDark, April 8, 2019

Exclusive: Meet the Nominees of This Year’s NEVY Awards
-BostonInno, March 27, 2019

Local company working on treatment to reverse hearing loss
- "The Cutting Edge" WCVB Channel 5, March 1, 2019

Frequency Therapeutics to Present at the 42nd Annual Mid-Winter Meeting of the Association for Research in Otolaryngology
- Press of Atlantic City, February 7, 2019

Term Sheet -- Tuesday, January 8
- Fortune, January 8, 2019

Pro Rata Podcast - Top of the Morning
- Axios, January 7, 2019

Frequency Therapeutics secures $42m from Taiwania Capital, Axil, others
- Deal Street Asia, January 7, 2019

Frequency Therapeutics Completes $42M Series B Financing
- FINSMES, January 7, 2019

Frequency Therapeutics raises $42m for hearing regeneration drug
- Drug Delivery Business News, January 7, 2019

Frequency Therapeutics raises $42m for hearing regeneration drug
- Mass Device, January 7, 2019

Frequency Therapeutics scores $42 mln Series B
- PE Hub, January 7, 2019

Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More
- Xconomy, January 7, 2019

Frequency Nabs $42M for Hearing Loss Drugs, Clinical Data On The Way
- Xconomy, January 7, 2019

Scrip Asks... What Will 2019 Hold For Biopharma? Part 1: Therapeutic Advances
- Scrip Intelligence, December 24, 2018

Custom earbuds could save your hearing. Why haven’t they taken off?
- Fast Company, November 16, 2018

Baystate Business: Papa Ginos, Rhode Island, Elections (Radio)
- Bloomberg Baystate Business Hour, November 5, 2018

Frequency completes enrollment in safety trial for hearing loss drug
- Drug Delivery Business News, October 4, 2018

Frequency completes enrollment in safety trial for hearing loss drug
- MassDevice, October 4, 2018

EmTech MIT: How AI and biomedical innovations are transforming health care
- ZD Net, September 19, 2018

Harvard Scientists: 'Smoking-Gun Evidence' Of Key To Hearing In Ear's Hair Cells
- WBUR, August 22, 2018

Frequency treats first patients in Phase I/II trial of FX-322
- Drug Development Technology, August 9, 2018

Frequency sounds out progenitor cell activation for hearing restoration
- in-pharmatechnologist, August 9, 2018

Frequency Therapeutics launches clinical trial for hearing loss drug
- MassDevice, August 7, 2018

NEA, 5AM back a $50M play to steer gene therapies to the clinic at Akouos — the latest startup in hearing
- Endpoints News, August 7, 2018

Frequency Therapeutics launches clinical trial for hearing loss drug
- Drug Delivery Business News, August 7, 2018

MIT names 35 top young innovators in technology
- Boston Herald, June 28, 2018

MIT Technology Review Innovators Under 35: Hearing loss in humans has always been irreversible. His innovation may change that
- MIT Technology Review, June 27, 2018

Women And People Of Color Are Underrepresented In Mass. BioTech. That Has To Change
- WBUR, David Lucchino, June 6, 2018

In The Heart Of Biotech, Leaders Explain The Boston Area’s 'BioBoom'
- WBUR, Karen Weintraub, June 4, 2018

Frequency Therapeutics Develops Small-Molecule Drugs to Treat Hearing Loss
- Genetic Engineering & Biotechnology News, June 1, 2018

Farmington biotech receives $2M grant for hearing-loss research
- Hartford Business Journal, May 30, 2018

Hear hear
- Chemistry & Industry News, May 16, 2018

Frequency Therapeutics Names William Chin Chief Medical Officer
- Xconomy, April 18, 2018

Retire? Bill Chin’s tried it three times, and he’d rather be working at Frequency Therapeutics
- Endpoints, April 13, 2018

Former Otonomy CSO LeBel Joins Frequency Therapeutics as Executive VP
- Xconomy, March 12, 2018

Toward a true cure for hearing impairment - Will McLean, Co-founder and Vice President, Biology and Regenerative Medicine
- Science, March 9, 2018

Biotech startup CEO David Lucchino to helm MassBio board
- Boston Business Journal, February 26, 2018

Five things you should know about David Lucchino
- The Boston Globe, February 2, 2018

New Jab Signals End of Hearing Aid
- The Guardian, January 19, 2018

UConn Technology Incubation Companies Raise $60M in 2017
- UConn Today, January 18, 2018

UConn startups raise record-setting $60M in funding in 2017
- Hartford Business, January 15, 2018

UConn Technology Incubation Program Companies Raise $60M In 2017
- Benzinga, January 12, 2018

Eric Clapton Losing His Hearing: Can High-Tech Fixes Help Boomers?
- Newsmax, January 11, 2018

Baby boomers destroyed their hearing. Biotech is trying to fix it
- The Boston Globe, January 10, 2018

Breakthrough drugs offer hope for the 360 million people with hearing loss
- CNBC, January 2, 2018

Frequency Completes Human Progenitor Cell Activation Study to Restore Hearing
- Genetic Engineering & Biotechnology News, December 21, 2017

Humans Have Regenerative Abilities—Scientists Just Need to Turn Them On
- Big Think, November 13, 2017

The Bloomberg Baystate Business Hour: Bosox and Biotech
- Bloomberg, October 11, 2017

Recovering lost hearing, without aids or implants
- Bloomberg North, August 22, 2017

A race is underway to repair our hearing — with medicine
- TechCrunch, July 28, 2017

Hartford Business Journal's 40 Under Forty - Will McLean
- Hartford Business Journal, July 14, 2017

Hearing Restoration: A Step Closer?
- JAMA, July 7, 2017

Targeting Progenitor Cells to Regenerate Damaged Tissue 
- Genetic Engineering & Biotechnology News, June 15, 2017

Interest rekindles in drug cocktails that reprogram cells
- Nature Biotechnology, June 7, 2017

Companies To Watch: Frequency Therapeutics
- Life Science Leader, June 7, 2017

Innovator's Corner: Regenerative Medicine Research Tackles Hearing Loss
- PharmaVOICE, June, 2017 Issue

Local company testing revolutionary hearing treatment
- "Cutting Edge with Mike Wankum" WCVB Channel 5, May 12, 2017

Farmington Medical Startup Targets Hearing Loss With New Drugs
- Hartford Courant, May 8, 2017

The 10 hottest medtech startups of 2017
- Medical Design & Outsourcing, April 21, 2017

Frequency Therapeutics launches to tackle hearing loss
- Chemical & Engineering News, April 12, 2017

Biotech Startup, Frequency Therapeutics, Nets $32 Million Investment
- Hearing Health & Technology Matters, April 12, 2017

Faster, simpler than CRISPR? Investors tune into Frequency Therapeutics
- PharmaPhorum, April 12, 2017

Frequency locks on $32M series A for hearing loss drug
- BioWorld, April 12, 2017

Frequency Therapeutics Raises $32M Series A Financing
- FINSMES, April 11, 2017

Frequency raises $32m in Series A for hearing loss therapy
- Drug Delivery Business News, April 11, 2017

Two new Series A rounds inject $72M into regenerative medicine and NASH
- MedCity News, April 11, 2017

Frequency Raises $32M to Advance Development of Hearing Loss Therapy
- Drug Discovery and Development News, April 11, 2017

Frequency Raises $32M in Series A to Develop Progenitor Cell Therapy for Hearing Loss
- Genetic Engineering & Biotechnology News, April 11, 2017

Investors chime in with $32M for Frequency's hearing loss program
- FierceBiotech, April 11, 2017

Frequency Therapeutics gets a $32M startup round to help fine tune its hearing loss drug R&D
- Endpoints, April 11, 2017

Frequency Nabs $32M, Will Push Hearing-Loss Drugs To Human Studies
- Xconomy, April 11, 2017

Hearing loss biotech Frequency Therapeutics dials up $32M round
- Boston Business Journal, April 11, 2017

Could an injection reverse hearing loss? This Woburn startup thinks so
- The Boston Globe, April 11, 2017

The stem cell therapy that could reverse hearing loss
- Drug Delivery Business News, March 23, 2017

This new treatment could combat hearing loss by regenerating hair cells in the inner ear
- PRI, March 20, 2017

Progress in treating hearing loss
- Harvard Gazette, March 15, 2017

Study Shows Hair Cell Regrowth with New Drug
- The Hearing Review, February 27, 2017

Stem cells offer potential treatment for hearing loss
- BioNews, February 27, 2017

Can This Treatment Combat Hearing Loss?
- Science Friday, February 24, 2017

Can you hear me now? Researchers one step closer to reversing hearing loss
- Digital Trends, February 24, 2017

Drug Combo Can Regenerate Hair Cells, May Restore Hearing Loss
- Genetic Engineering & Biotechnology News, February 22, 2017

Scientists work to regenerate the cells lost after loud noises
- STAT News, February 22, 2017

Stem Cell Therapy Could Reverse Hearing Loss
- Seeker, February 22, 2017

A New Drug Injection Could Reverse Hearing Loss
- The Huffington Post: HuffPost Tech UK, February 22, 2017

Reprogramming Hair Cells
- The Scientist, February 22, 2017

Could a jab stop old people from going DEAF? Scientists create a drug that can restore crucial hair to the inner ear and allows them to keep their hearing
- Daily Mail, February 21, 2017

HAIR RAISING IDEA Simple injection in the ear can ‘CURE the leading form of deafness’
- The Sun, February 21, 2017

Drug treatment could combat hearing loss
- MIT News, February 21, 2017

Researchers devise method for regenerating hair cells to help reverse hearing loss
- Tech Crunch, February 21, 2017

Local Researchers May Have Found a Way to Treat Hearing Loss
- Boston Magazine, February 21, 2017

Hear This: Scientists Regrow Sound-Sensing Cells
- LiveScience, February 21, 2017

Suffering with hearing loss? ‘Miracle’ jab used to treat infections could CURE deafness
- Express, February 21, 2017

Two biotech startups tackle hearing loss
- MedCity News, January 9, 2017

Frequency Therapeutics names board of directors
- Drug Delivery Business News, January 9, 2017

Another Langer-backed biotech breaks out of stealth mode, aims for the clinic with hearing loss therapy
- Endpoints News, January 5, 2017

Frequency, Led by MIT’s Langer, Aims to Fight Hearing Loss With Drugs
- Xconomy, January 5, 2017

Gels to Repair Hearing Loss? Drugmakers Try New Ear Treatments
- Bloomberg, October 14, 2016

Human Hearing Loss Could Be Reversible
- The Atlantic, July 19, 2016